Table 2.

General description of the COVID-19 vaccinated study population.

	% (n) unless otherwise specified
N*	230
Female	75% (1 7 2)
Age category in years
-18–65	77% (1 7 7)
-66–91	23% (53)
Healthcare worker	75% (1 72)
Vaccination
-Two doses	51% (1 1 8)
-Median days since first vaccination, range (IQR)	24, 0–59 (14–32)
Past SARS-CoV-2 infection
-No	78% (1 7 9)
-(Self-reported) RT-qPCR positive	14% (32)
-Seroconversion IgG to Spike S1 prior to vaccination	8% (19)

IQR: interquartile range; IgG: immunoglobulin G.

^*See Supplementary Fig. 2A and 2C for more information on sample availability and exclusion criteria.